BioCentury | Sep 24, 2019
Financial News

BioNTech will do without $100M from Hong Kong-based series B investor

...investors in Europe and Asia.” Another series B investor, BVCF Management, is headquartered in Shanghai. BVCF...
BioCentury | Sep 11, 2019
Financial News

BioNTech IPO filing says trade war, Hong Kong unrest may be delaying $100M of series B

...Europe and Asia.” Another series B investor, BVCF Management, is headquartered in Shanghai. Neither Jebsen’s, BVCF’s...
BioCentury | Jul 9, 2019
Financial News

BioNTech broadens investor base with $325M B round

...Platinum Asset Management, Hong Kong’s Jebsen Capital, Europe and Asia-focused Steam Athena Capital and Shanghai’s BVCF...
BioCentury | Jun 22, 2018
Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

...Pivotal Beta and Morningside Ventures, respectively. Also participating were funds associated with Atlantis Investment Management, BVCF...
BioCentury | Jun 18, 2018
Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

...by Nan Fung Technology's Pivotal Beta. Also participating were funds associated with Atlantis Investment Management, BVCF...
BioCentury | Dec 8, 2017
Financial News

Tasly unit invests $50M in Chinese diabetes play Genova

...insulin analogs for the Chinese and European markets. The company’s investors include BioVeda China Fund (BVCF...
BioCentury | Dec 8, 2017
Financial News

Anti-infectives company MicuRx raises RMB100M

...million) on Dec. 6 in a private placement led by existing investors Delian Capital and BVCF...
BioCentury | Dec 6, 2017
Financial News

Anti-infectives company MicuRx raises RMB100M

...RMB100 million ($15.1 million) in a private placement led by existing investors Delian Capital and BVCF...
BioCentury | Jan 26, 2016
Financial News

Chinese CAR-T play CARsgen raises $30M

...2014, CARsgen raised more than $10 million in a venture round from private equity firm BVCF...
BioCentury | Jan 19, 2015
Company News

DiaCarta board of directors update

DiaCarta Inc. , Hayward, Calif. Business: Diagnostic, Supply/Service Appointed: Weixin Xu, principal at BVCF WIR Staff Diagnostic...
Items per page:
1 - 10 of 20
BioCentury | Sep 24, 2019
Financial News

BioNTech will do without $100M from Hong Kong-based series B investor

...investors in Europe and Asia.” Another series B investor, BVCF Management, is headquartered in Shanghai. BVCF...
BioCentury | Sep 11, 2019
Financial News

BioNTech IPO filing says trade war, Hong Kong unrest may be delaying $100M of series B

...Europe and Asia.” Another series B investor, BVCF Management, is headquartered in Shanghai. Neither Jebsen’s, BVCF’s...
BioCentury | Jul 9, 2019
Financial News

BioNTech broadens investor base with $325M B round

...Platinum Asset Management, Hong Kong’s Jebsen Capital, Europe and Asia-focused Steam Athena Capital and Shanghai’s BVCF...
BioCentury | Jun 22, 2018
Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

...Pivotal Beta and Morningside Ventures, respectively. Also participating were funds associated with Atlantis Investment Management, BVCF...
BioCentury | Jun 18, 2018
Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

...by Nan Fung Technology's Pivotal Beta. Also participating were funds associated with Atlantis Investment Management, BVCF...
BioCentury | Dec 8, 2017
Financial News

Tasly unit invests $50M in Chinese diabetes play Genova

...insulin analogs for the Chinese and European markets. The company’s investors include BioVeda China Fund (BVCF...
BioCentury | Dec 8, 2017
Financial News

Anti-infectives company MicuRx raises RMB100M

...million) on Dec. 6 in a private placement led by existing investors Delian Capital and BVCF...
BioCentury | Dec 6, 2017
Financial News

Anti-infectives company MicuRx raises RMB100M

...RMB100 million ($15.1 million) in a private placement led by existing investors Delian Capital and BVCF...
BioCentury | Jan 26, 2016
Financial News

Chinese CAR-T play CARsgen raises $30M

...2014, CARsgen raised more than $10 million in a venture round from private equity firm BVCF...
BioCentury | Jan 19, 2015
Company News

DiaCarta board of directors update

DiaCarta Inc. , Hayward, Calif. Business: Diagnostic, Supply/Service Appointed: Weixin Xu, principal at BVCF WIR Staff Diagnostic...
Items per page:
1 - 10 of 20